Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection.
Svensson
M
M
Department of Laboratory Medicine, Division of Microbiology, Immunology and Glycobiology, Lund University, 223 62 Lund, Sweden. majlis.svensson@mig.lu.se
Platt
F
F
Frendeus
B
B
Butters
T
T
Dwek
R
R
Svanborg
C
C
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D001422:Bacterial Adhesion / Q000187:drug effects; D004926:Escherichia coli / Q000378:metabolism / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000378:metabolism / Q000517:prevention & control; D010861:Fimbriae, Bacterial / Q000378:metabolism; D006017:Glycolipids / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism; D006028:Glycosphingolipids / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000209:etiology; D014552:Urinary Tract Infections / Q000378:metabolism / Q000517:prevention & control*
D006017:Glycolipids; D006028:Glycosphingolipids; D017485:1-Deoxynojirimycin; C090092:migalastat